Lack of detectable platelet autoantibodies is correlated with nonresponsiveness to rituximab treatment in ITP patients

Porcelijn, L., Huiskes, E., Schipperus, M., Van Der Holt, B., De Haas, M., & Zwaginga, J. J. (2017, June 22). Lack of detectable platelet autoantibodies is correlated with nonresponsiveness to rituximab treatment in ITP patients. Blood. American Society of Hematology. https://doi.org/10.1182/blood-2016-11-751719